Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

High-dose atorvastatin associated with worse glycemic control: A PROVE-IT TIMI 22 substudy

High-dose atorvastatin associated with worse glycemic control: A PROVE-IT TIMI 22 substudy. Circulation. 2004; 110(17):III-834.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.